Treatment Of Breast Cancer

Patent No. EP2739153 (titled "Treatment Of Breast Cancer") was filed by Medivation Prostate Therapeutics on Jul 27, 2012. The application was issued on Aug 22, 2018.

Patent Summary

Therapeutic drug for breast cancer that reduces tumor size. The drug is formulated in a pharmaceutical composition including diarylhydantoin compounds, and the drug is administered to a patient in a dose dependent manner.

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKMay 21, 2019ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2739153

MEDIVATION PROSTATE THERAPEUTICS
Application Number
EP12846720A
Filing Date
Jul 27, 2012
Status
Opposition Rejected
Jun 11, 2021
Publication Date
Aug 22, 2018